CD36 and cancer: Previous studies have demonstrated that CD36 levels are upregulated in some malignancies, such as ovarian cancer (104), breast cancer (107), gastric cancer (108), oral cancer (109), melanoma (110), and colorectal cancer (111), to maintain cancer cell progression and metastasis.